Tag Archives: NAVB

Top 10 Stocks To Buy For 2019

Calavo Growers, Inc. (NASDAQ:CVGW), which I’ve dubbed a “tiny, mighty dividend stock,” reported fiscal second-quarter 2018 earnings on June 6. How has this dynamic avocado market specialist fared so far in its fiscal year? Let’s dive into the quarter’s details after first walking through headline numbers directly below.

Calavo: The raw numbers

Metric Q2 2018 Q2 2017 Year-Over-Year Growth

Revenue $264.4 million $270.2 million (2.1%)
Net income  $14.2 million $12.9 million 11.5%
Diluted earnings per share $0.81 $0.74 9.5%

Data source: Calavo Growers, Inc.

What happened this quarter?

Calavo’s largest segment, fresh foods, which derives sales from avocados sourced from its cooperative California growers and Latin American suppliers, achieved double-digit volume growth. However, revenue decreased from $155.6 million to $137.9 million as historic avocado prices from the prior year (due to a spike from short supply) normalized in 2018.

Top 10 Stocks To Buy For 2019: Materialise NV(MTLS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Blackline (NASDAQ: MTLS) and Materialise (NASDAQ:MTLS) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.

  • [By Stephan Byrd]

    Materialise (NASDAQ:MTLS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

    Royal Caribbean Cruises (NYSE:RCL) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

  • [By Logan Wallace]

    News coverage about Materialise (NASDAQ:MTLS) has been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Materialise earned a media sentiment score of 0.06 on Accern’s scale. Accern also assigned news headlines about the software maker an impact score of 46.5867221134452 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Materialise (MTLS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Materialise (NASDAQ:MTLS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

    Navigator (NYSE:NVGS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

  • [By Logan Wallace]

    TheStreet upgraded shares of Materialise (NASDAQ:MTLS) from a c+ rating to a b- rating in a research report report published on Thursday.

    Several other brokerages have also commented on MTLS. BidaskClub upgraded shares of Materialise from a sell rating to a hold rating in a report on Tuesday, August 28th. ValuEngine upgraded shares of Materialise from a hold rating to a buy rating in a report on Friday, August 24th. Finally, Zacks Investment Research lowered shares of Materialise from a hold rating to a strong sell rating in a report on Thursday, August 9th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. The company presently has an average rating of Hold and an average target price of $19.00.

Top 10 Stocks To Buy For 2019: Portola Pharmaceuticals, Inc.(PTLA)

Advisors’ Opinion:

  • [By ]

    Portola Pharmaceuticals (PTLA) : “The news is already in this story. I’d rather be in something better.”

    STMicroelectronics (STM) : “No. You want Cisco Systems (CSCO) ahead of when they report.”

  • [By Logan Wallace]

    Portola Pharmaceuticals (NASDAQ:PTLA) has been given a $80.00 target price by equities research analysts at Oppenheimer in a research note issued to investors on Sunday. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. Oppenheimer’s price target points to a potential upside of 88.50% from the stock’s previous close.

  • [By Joseph Griffin]

    Portola Pharmaceuticals (NASDAQ:PTLA)‘s stock had its “underperform” rating reissued by research analysts at Credit Suisse Group in a report released on Friday, MarketBeat Ratings reports. They presently have a $28.00 price target on the biopharmaceutical company’s stock, down from their prior price target of $49.00. Credit Suisse Group’s price objective would indicate a potential downside of 3.95% from the stock’s previous close.

Top 10 Stocks To Buy For 2019: Infinera Corporation(INFN)

Advisors’ Opinion:

  • [By Billy Duberstein]

    For a great example, look no further than the recent note from MKM analyst Michael Genovese. Genovese anticipates large systems vendor Ciena (NYSE:CIEN) may end up stealing away large customer CenturyLink (NYSE:CTL) from smaller competitor Infinera (NASDAQ:INFN). That could be a huge win for Ciena and a huge blow to Infinera, and the episode is emblematic of this period in the industry.

  • [By Max Byerly]

    Infinera (NASDAQ:INFN) was the recipient of unusually large options trading activity on Thursday. Stock investors bought 3,256 put options on the company. This is an increase of approximately 841% compared to the typical daily volume of 346 put options.

  • [By Brian Feroldi]

    Infinera (NASDAQ:INFN) reported its first-quarter results on Wednesday, May 9. Management at the optical equipment provider told investors last quarter that revenue and margins were starting to rebound nicely from their 2017 lows. But did the company keep its momentum up in the first-quarter? Let’s dig into the numbers to find out.

  • [By Joseph Griffin]

    Infinera Corp. (NASDAQ:INFN)’s share price traded down 10.2% during trading on Thursday . The stock traded as low as $7.59 and last traded at $7.59. 5,231,115 shares traded hands during mid-day trading, an increase of 215% from the average session volume of 1,658,666 shares. The stock had previously closed at $8.45.

  • [By Brian Feroldi]

    Shares of optical equipment provider Infinera (NASDAQ:INFN) plunged as much as 18% in early-morning trading on Monday. Shares were down about 14% as of 10:20 a.m. EDT. An analyst downgrade appears to be the primary reason for the big downward move.

Top 10 Stocks To Buy For 2019: Liberty TripAdvisor Holdings, Inc.(LTRPA)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares jumped 31.6 percent to $12.18 following TripAdvisor Q1 earnings beat.
    ZAGG Inc (NASDAQ: ZAGG) rose 26.5 percent to $14.55 after the company posted better-than-expected Q1 earnings.
    OPKO Health, Inc. (NASDAQ: OPK) shares gained 25 percent to $4.0234 following Q1 beat.
    Axon Enterprise, Inc. (NASDAQ: AAXN) jumped 23.5 percent to $55.12 following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Penn Virginia Corporation (NASDAQ: PVAC) gained 23.3 percent to $59.00 after reporting Q1 results.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 22.5 percent to $47.51 after the company reported stronger-than-expected results for its first quarter on Tuesday.
    Sears Holdings Corporation (NASDAQ: SHLD) shares surged 21.7 percent to $3.36. Amazon.com's partnership with Sears started in 2017 with an agreement to sell Kenmore-branded appliances online. On Wednesday, the companies announced an extension of their relationship to now include tire delivery and installations.
    EP Energy Corporation (NYSE: EPE) jumped 21.3 percent to $2.68 following Q1 results.
    LendingClub Corporation (NYSE: LC) surged 20.4 percent to $3.395 following better-than-expected Q1 earnings.
    Superior Industries International, Inc. (NYSE: SUP) gained 19 percent to $15.82 after reporting Q1 results.
    Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) shares rose 18.5 percent to $8.13 following Q1 results.
    Twilio Inc. (NYSE: TWLO) rose 18.3 percent to $52.47 after the company posted strong quarterly results.
    Cerus Corporation (NASDAQ: CERS) shares jumped 18.3 percent to $6.47 following quarterly results.
    IEC Electronics Corp. (NYSE: IEC) shares climbed 17 percent to $4.68 after reporting better-than-expected quarterly earnings.
    New Relic, Inc. (NYSE: NEWR) rose 16.8 percent to $90.10 following Q4 results.
    Gulfport Energy Corporation (NASDAQ: GPOR)
  • [By Ethan Ryder]

    Engineers Gate Manager LP acquired a new position in Liberty Tripadvisor Holdings Inc Series A (NASDAQ:LTRPA) during the second quarter, Holdings Channel reports. The fund acquired 102,003 shares of the technology company’s stock, valued at approximately $1,642,000.

  • [By Lisa Levin]

    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares shot up 30 percent to $12.05 following TripAdvisor Q1 earnings beat.

    Shares of ZAGG Inc (NASDAQ: ZAGG) got a boost, shooting up 26 percent to $14.48 after the company posted better-than-expected Q1 earnings.

  • [By Max Byerly]

    Liberty Tripadvisor Holdings Inc Series A (NASDAQ:LTRPA) saw a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 2,070,644 shares, an increase of 47.7% from the May 15th total of 1,402,097 shares. Currently, 2.9% of the company’s stock are short sold. Based on an average daily trading volume, of 839,315 shares, the short-interest ratio is currently 2.5 days.

  • [By Lisa Levin]

    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares shot up 31 percent to $12.10 following TripAdvisor Q1 earnings beat.

    Shares of ZAGG Inc (NASDAQ: ZAGG) got a boost, shooting up 34 percent to $15.3628 after the company posted better-than-expected Q1 earnings.

  • [By Lisa Levin]

    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares shot up 32 percent to $12.175 following TripAdvisor Q1 earnings beat.

    Shares of ZAGG Inc (NASDAQ: ZAGG) got a boost, shooting up 27 percent to $14.60 after the company posted better-than-expected Q1 earnings.

Top 10 Stocks To Buy For 2019: Navidea Biopharmaceuticals, Inc.(NAVB)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    After looking at last week’s top performing penny stocks, we’ll show you a penny stock that’s on the verge of bringing you triple-digit returns…

    Penny Stock Current Share Price Last Week’s Gain
    Orchids Paper Products Co. (NYSE: TIS) $2.60 218.83%
    China Rapid Finance Ltd. (NYSE: XRF) $2.69 69.01%
    Cel-Sci Corp. (NYSE: CVM) $1.21 42.17%
    Regulus Therapeutics Inc. (Nasdaq: RGLS) $0.29 33.40%
    Farmmi Inc. (Nasdaq: FAMI) $3.82 30.51%
    Biolase Inc. (Nasdaq: BIOL) $1.85 29.93%
    Navidea Biopharmaceuticals Inc. (NYSE: NAVB) $0.18 26.99%
    Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $0.92 25.56%
    Inpixon (Nasdaq: INPX) $0.14 24.36%
    JMU Ltd. (Nasdaq: JMU) $1.58 24.05%

    While some of those returns look spectacular, we’re not convinced these penny stocks will keep growing.

  • [By Money Morning Staff Reports]

    After looking at last week’s top performing penny stocks, we’ll show you a small-cap stock with real growth potential that just popped up on our radar…

    Penny Stock Current Share Price Last Week’s Gain
    New Age Beverage Corp. (NADAQ: NBEV) $3.94 286.79%
    India Globalization Capital Inc. (NYSE: IGC) $2.18 181.55%
    Ascent Capital Group Inc. (NASDAQ: ASCMA) $2.16 103.85%
    Netlist Inc. (NASDAQ: NLST) $0.73 80.56%
    Oragenics Inc. (NYSE: OGEN) $0.92 71.63%
    Astrotech Corp. (NASDAQ: ASTC) $3.44 68.37%
    Command Security Corp. (NYSE: MOC) $2.77 51.09%
    Oasmia Pharmaceuticals (NASDAQ: OASM) $3.57 50.66%
    NovaBay Pharmaceuticals Inc. (NYSE: NBY) $2.10 48.15%
    Navidea Biopharmaceuticals Inc. (NYSE: NAVB) $0.25 45.72%

    While the gains these stocks made are exciting, they also highlight the danger of investing in penny stocks.

Top 10 Stocks To Buy For 2019: Exterran Corporation(EXTN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    United Rentals (NYSE: URI) and Exterran (NYSE:EXTN) are both construction companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Exterran (EXTN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Exterran (EXTN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Exterran (EXTN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Buy For 2019: AdvanSix Inc. (ASIX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    GSA Capital Partners LLP reduced its holdings in AdvanSix Inc (NYSE:ASIX) by 36.7% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 24,620 shares of the company’s stock after selling 14,277 shares during the quarter. GSA Capital Partners LLP owned about 0.08% of AdvanSix worth $856,000 as of its most recent filing with the SEC.

  • [By Max Byerly]

    AdvanSix (NYSE:ASIX) Director Michael Marberry bought 1,398 shares of the stock in a transaction on Monday, May 7th. The stock was purchased at an average price of $35.74 per share, for a total transaction of $49,964.52. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.

  • [By Joseph Griffin]

    AdvanSix Inc (NYSE:ASIX) shares hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $32.23 and last traded at $32.33, with a volume of 2848 shares trading hands. The stock had previously closed at $32.70.

Top 10 Stocks To Buy For 2019: Union Pacific Corporation(UNP)

Advisors’ Opinion:

  • [By Max Byerly]

    News stories about Union Pacific (NYSE:UNP) have been trending somewhat positive this week, Accern reports. The research firm rates the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Union Pacific earned a media sentiment score of 0.11 on Accern’s scale. Accern also assigned media stories about the railroad operator an impact score of 46.138597756114 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

  • [By Stephan Byrd]

    Here are some of the headlines that may have impacted Accern Sentiment’s analysis:

    Get Union Pacific alerts:

    Union Pacific to close downtown DeKalb railroad crossing (daily-chronicle.com) Union Pacific ordered to flag traffic at Monroe County crossing with history of failing gates (lacrossetribune.com) Union Pacific Reaches Analyst Target Price (forbes.com) Does Union Pacific’s Free Cash Flow Suggest a Rise in 2018? (finance.yahoo.com) Union Pacific Co. (UNP) Expected to Post Quarterly Sales of $5.53 Billion (americanbankingnews.com)

    Several equities analysts recently issued reports on the company. TD Securities lowered their price target on Union Pacific from $155.00 to $150.00 and set a “buy” rating on the stock in a research note on Friday, January 26th. Robert W. Baird restated a “hold” rating on shares of Union Pacific in a research note on Friday, January 26th. UBS lowered their price target on Union Pacific from $164.00 to $162.00 and set a “buy” rating on the stock in a research note on Friday, January 26th. Seaport Global Securities lowered Union Pacific from a “buy” rating to a “neutral” rating in a research note on Friday, January 26th. They noted that the move was a valuation call. Finally, Loop Capital boosted their price target on Union Pacific from $137.00 to $145.00 and gave the company a “hold” rating in a research note on Monday, April 16th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and twelve have given a buy rating to the company’s stock. Union Pacific presently has an average rating of “Hold” and a consensus target price of $138.95.

  • [By Matthew DiLallo]

    In addition to the capacity from that pipeline, railroads are looking for ways to help ease the bottleneck in the near term by shipping some crude by rail. “The [Permian] is an interesting place, and we’re definitely seeing some reduction in crude production due to the lack of pipelines,” said Beth Whited, the chief marketing officer of Union Pacific (NYSE:UNP) on the company’s second-quarter call. Union Pacific has “some capacity in our network and expects to see some results in the third and fourth quarter.” Since that time, Union Pacific struck a deal with a logistics company to ship about 400,000 barrels per month of crude on its system through next year, with the potential for it to last into 2020.

  • [By Ethan Ryder]

    Here are some of the media stories that may have effected Accern’s analysis:

    Get Union Pacific alerts:

    Union Pacific (UNP) Price Target Raised to $155.00 at Robert W. Baird (americanbankingnews.com) Seaport Global Securities Comments on Union Pacific Co.’s FY2019 Earnings (UNP) (americanbankingnews.com) Union Pacific Co. (UNP) Expected to Announce Quarterly Sales of $5.54 Billion (americanbankingnews.com) Zacks: Brokerages Anticipate Union Pacific Co. (UNP) Will Post Earnings of $1.88 Per Share (americanbankingnews.com) Jobs report shows we have 'perfect economy' for stocks (finance.yahoo.com)

    A number of equities research analysts recently issued reports on the company. Morgan Stanley lifted their target price on Union Pacific from $125.00 to $136.00 and gave the company an “equal weight” rating in a research report on Friday. Cowen reissued a “market perform” rating and issued a $153.00 target price (up previously from $140.00) on shares of Union Pacific in a research report on Friday. Robert W. Baird lifted their target price on Union Pacific from $144.00 to $155.00 and gave the company a “neutral” rating in a research report on Monday. TD Securities dropped their target price on Union Pacific from $155.00 to $150.00 and set a “buy” rating on the stock in a research report on Friday, April 27th. Finally, Loop Capital lifted their target price on Union Pacific to $153.00 and gave the company a “hold” rating in a research report on Friday. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and twelve have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $146.70.

  • [By Asit Sharma]

    With these words, Union Pacific (NYSE:UNP) chief Lance Fritz shifted the conversation during the company’s first-quarter earnings conference call with analysts on April 26, from a discussion on a relatively successful quarter to a prolonged question-and-answer session addressing analysts’ concerns over the railroad’s productivity. 

  • [By Max Byerly]

    Roberts Glore & Co. Inc. IL decreased its position in Union Pacific Co. (NYSE:UNP) by 5.6% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,853 shares of the railroad operator’s stock after selling 465 shares during the quarter. Roberts Glore & Co. Inc. IL’s holdings in Union Pacific were worth $1,113,000 as of its most recent filing with the SEC.

Top 10 Stocks To Buy For 2019: Skyworks Solutions, Inc.(SWKS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Skyworks Solutions Inc (NASDAQ:SWKS) Director David J. Aldrich sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, August 24th. The shares were sold at an average price of $92.89, for a total transaction of $928,900.00. Following the completion of the transaction, the director now owns 152,252 shares of the company’s stock, valued at approximately $14,142,688.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

  • [By Matthew Cochrane]

    Of course, as it’s been a full nine years since the stock market took off on this amazing bull run, stocks that fit that description have become harder  to find — but not impossible. Here are two tech stocks that are not only wonderful companies, but trade at darn near wonderful prices too. Let’s take a closer look at HP Inc. (NYSE:HPQ) and Skyworks Solutions (NASDAQ:SWKS) to see why they would make wonderful additions to any portfolio.

  • [By Benzinga News Desk]

    Former President George H.W. Bush has been hospitalized in Houston with an infection, just after attending the funeral of his wife, Barbara, a spokesman said Monday: Link

    ECONOMIC DATA
    Redbook Reports US Retail Sales During First 2 Weeks Of Apr. Up 0.3% MoM, Up 2.8% YoY
    USA S&P/CaseShiller House Price Index (MoM) for Feb Up 0.7% MoM
    New home sales report for March will be released at 10:00 a.m. ET.
    The Conference Board’s consumer sentiment index for April is schedule for release at 10:00 a.m. ET.
    The Richmond Fed manufacturing index for April will be released at 10:00 a.m. ET.
    The Treasury is set to auction 4-and 52-week bills at 11:30 a.m. ET.
    The Treasury will auction 2-year notes at 1:00 p.m. ET.
    ANALYST RATINGS
    Leerink upgraded Cardinal Health (NYSE: CAH) from Market Perform to Outperform
    Berenberg upgraded Emerson Electric (NYSE: EMR) from Sell to Hold
    Mizuho downgraded Skyworks (NASDAQ: SWKS) from Buy to Neutral
    BMO downgraded Texas Roadhouse (NASDAQ: TXRH) from Outperform to Market Perform

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

Top 10 Stocks To Buy For 2019: Cambrex Corporation(CBM)

Advisors’ Opinion:

  • [By George Budwell, Chuck Saletta, and Todd Campbell]

    So, with the biotech space solidly on the comeback trail, we asked three of our Motley Fool contributors which stocks they think are poised to keep churning higher in February and perhaps for the remainder of the year. They suggested Viking Therapeutics (NASDAQ:VKTX), Cambrex (NYSE:CBM), and Sarepta Therapeutics (NASDAQ:SRPT). Here’s why.     

  • [By Motley Fool Transcribers]

    Cambrex Corp  (NYSE:CBM)Q4 2018 Earnings Conference CallFeb. 13, 2019, 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Money Morning Staff Reports]

    Cambrex Corp. (NYSE: CBM) was founded in 1981 and is a leading supplier of generic active pharmaceutical ingredients (APIs).

    Cambrex has more than 100 generic APIs, and 90 of them are commercially sold.

  • [By Logan Wallace]

    Shares of Cambrex Co. (NYSE:CBM) have earned a consensus recommendation of “Hold” from the six brokerages that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $60.00.

Best Stocks For 2019

If you’re itching to start investing in the stock market, who could blame you? It’s where Warren Buffett and countless others have made much of their money, and it’s just about the best way to build wealth over the long term. But hold your horses: First use these six questions as a checklist to make sure you can afford to invest.

Image source: Getty Images.

1. Do you have $25 or more?

Let’s start with an easy question. Do you have some extra dollars? You might think you need a lot, as a single share of Warren Buffett’s company Berkshire Hathaway recently cost $162 — or $243,000! — depending on the class of shares. Amazon.com shares, meanwhile, were recently near $800 a pop, while Priceline Group shares topped $1,500 each. Gobs of companies trade at much lower stock prices, though — often below $100.

Best Stocks For 2019: Navidea Biopharmaceuticals, Inc.(NAVB)

Advisors’ Opinion:

  • [By Monica Gerson]

    Navidea Biopharmaceuticals Inc (NYSE: NAVB) shares rose 8.80 percent to $0.950 in pre-market trading as the company reported an unsolicited offer to refinance CRG loan.

Best Stocks For 2019: Waste Management, Inc.(WM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Avon Products, Inc. (NYSE: AVP) to report quarterly earnings at $0.10 per share on revenue of $1.62 billion before the opening bell. Avon Products shares rose 2.39 percent to $6.00 in after-hours trading.
    Analysts expect MGM Resorts International (NYSE: MGM) to report quarterly earnings at $0.20 per share on revenue of $2.44 billion before the opening bell. MGM shares rose 1.01 percent to $29.90 in after-hours trading.
    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected results for its second quarter and raised its quarterly dividend to $0.29 per share. Cisco shares rose 2.13 percent to $33.52 in the after-hours trading session.
    Before the markets open, Dean Foods Co (NYSE: DF) is projected to report its quarterly earnings at $0.41 per share on revenue of $2.01 billion. Dean Foods shares rose 0.49 percent to $20.55 in after-hours trading.
    Tripadvisor Inc (NASDAQ: TRIP) posted weaker-than-expected results for its fourth quarter on Wednesday. Tripadvisor shares dropped 5.60 percent to $49.75 in the after-hours trading session.
    Analysts are expecting Waste Management, Inc. (NYSE: WM) to have earned $0.77 per share on revenue of $3.42 billion in the latest quarter. Waste Management will release earnings before the markets open. Waste Management shares rose 2.27 percent to $72.97 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By ]

    For his “Executive Decision” segment, Cramer spoke with Jim Fish, president and CEO of Waste Management (WM) , which just posted an eight-cents-a-share earnings beat, but saw shares decline as investors worry over the impact of trade wars with China on the company’s recycling business.

  • [By Brian Feroldi]

    Investors in their 60’s should start to favor low-risk stocks that offer up big dividend payouts. Below are three stocks — Waste Management (NYSE:WM), United Parcel Service (NYSE:UPS), and Welltower (NYSE:HCN) — that perfectly fit that description.

  • [By ]

    For his “Executive Decision” segment, Cramer spoke with Jim Fish, president and CEO of Waste Management (WM) , which just posted an eight-cents-a-share earnings beat, but saw shares decline as investors worry over the impact of trade wars with China on the company’s recycling business.

Best Stocks For 2019: iShares Nasdaq Biotechnology Index Fund(IBB)

Advisors’ Opinion:

  • [By ]

    After sneaking lower to begin the new trading week, the SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels.

  • [By Ben Levisohn]

    Biotech stocks are having a great day today–iShares Nasdaq Biotechnology ETF (IBB) has climbed 2.5% to $276.92–leading some to suggest that 2017 could be better for investors than 2016 was. Not Baird’s Brian Skorney and Michael Ulz, who “don’t think 2017 will be worse than 2016″ but “aren’t quite sure it will be much better.” They explain why:

    Agence France-Presse/Getty Images

    Short story is, growth products are slowing and large net price increases are appearing increasingly unsustainable, even if the government doesn’t intervene. The innovation cycle appears to be in a waning period and, so far, large-caps with boatloads of cash seem to be hesitant to act. 2017 should have some excitement. We may finally see a successful registrational study in Alzheimer’s disease (Axovant Sciences’ (AXON) intepirdine or Merck’s (MRK) verubecestat), CAR T will finally get to plead its case, and we may find out once and for all if those ‘transformational’ PCSK9s are just that…

    A steadily building pharma cash war chest is a big offsetting tailwind. As Princess Leia would say, “Help me M&A, you’re my only hope.”

    Skorney’s namesVertex Pharmaceuticals (VRTX),Sarepta Therapeutics (SRPT), and Curis (CRIS) his top biotech picks for 2017, while Ulz chosesBioMarin Pharmaceutical (BMRN) andParatek Pharmaceuticals (PRTK).

  • [By WWW.THESTREET.COM]

    Biotechnology stocks had an incredible run between 2012 and 2015, and the iShares Nasdaq Biotechnology ETF (IBB) was up 395% in that time. After making the record high, however, the space came under pressure and the fund dropped below its 40-week moving average, eventually retracing 50% of its historic rally before finding support in the $240.00 area. Since that time, it has been moving in a horizontal channel below the 38% retracement level of the pullback range in the $300.00 area, and 2016 triple-bottom support.

  • [By Ben Levisohn]

    Shares of Amgen have dropped 0.8% to $146.61 at 2:44 p.m. today, while Regeneron Pharmaceutical has fallen 0.5% to $369.83, and Celgene has gained 2% to $118.10. The iShares Nasdaq Biotechnology ETF (IBB) has risen 0.4% to $269.86.

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) a good measure of small-cap biotech stocks gained almost 6% yesterday. Meanwhile, the large-cap iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) jumped almost 4%. The biotech buying frenzy helped lift the Nasdaq Composite to a gain of almost 1% in Mondays session.

  • [By ]

    October was not kind to the biggest names in biotech. While smaller, more speculative biotech names consolidated, the big kids fell off a cliff. The biotech slide accelerated midway through the month, with both the large-cap iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) and the smaller SPDR S&P Biotech ETF slipping more than 5%.

Top 10 Undervalued Stocks For 2018

If youre looking for an undervalued company in the auto segment thats almost guaranteed to grow slow and steady over the long term, then the Lear Corporation (LEA) should definitely be on your vetting list. The lowly PE ratio of 10 is merely the bitter aftertaste of investors in a company that went belly up during the great recession because of its debt pile. I believe the company has shaken off its old habits and is fiscally more responsible now. Moreover, it holds a large market share of the seat segment and a growing one in e-systems, the second of which addresses a growing auto electrification market. So lets look at how you, as an investor, can take advantage of the troubles this company has gone through and, more importantly, come out of.

The auto industry is on the verge of the greatest disruption of our times as automaker after automaker pursues technologies like autonomous vehicle technology, electrification and connectivity. Sure, you can take the driver out of the car, but you cant take away the seats! And thats where the Lear Corporation makes its plush entrance. With 2017 seat assembly sales of $15.9 billion representing nearly a fourth of the addressable market, Lear looms large in a relatively stable and growing niche of a highly disruptive segment.

Top 10 Undervalued Stocks For 2018: Tableau Software, Inc.(DATA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref
    Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref
    Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref
    Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref
    Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref
    Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref
    Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

Top 10 Undervalued Stocks For 2018: Viacom Inc.(VIA)

Advisors’ Opinion:

  • [By Keith Noonan]

    While 2016 played host to a range of films that underperformed, the biggest flops belonged to Disney (NYSE:DIS), Viacom (NASDAQ:VIA) (NASDAQ:VIAB) and Lions Gate Entertainment (NYSE:LGF.A). Click through the presentation below to get the details on the year’s five biggest film flops and to learn what last year’s movie misfires mean for the companies involved.

  • [By Douglas A. McIntyre]

    The Pillsbury Doughboy is the mascot of the Pillsbury Company, which is owned by General Mills (NYSE: GIS) and J.M. Smucker (NYSE: SJM). The Doughboy was created by Pillsburys advertising agency almost 50 years ago. Pikachu are characters owned by The Pokemon Company International and appear in card games, video games, TV shows, movies and comic books. Founded in 1998, the Japanese company has achieved total games sales of almost 280 million. SpongeBob SquarePants was created for Nickelodeon, which is owned by Viacom (NASDAQ: VIA). The show premiered in 1999 and has spawned movies, video games and theme park rides. Ronald McDonald is a c

Top 10 Undervalued Stocks For 2018: Lincoln National Corporation(LNC)

Advisors’ Opinion:

  • [By Lee Jackson]

    Lincoln National Corp. (NYSE: LNC) also had the man at the top selling stock last week. Dennis Glass, the CEO of this insurance and retirement focused company, sold a block of 75,000 shares at between $71.00 and $71.28 apiece. The total for the sale was posted at $5 million. Shares closed Friday at $71.69, in a 52-week rangeof $34.16 to $73.71. The consensus price target is $73.17.

  • [By WWW.THESTREET.COM]

    * The market bent yesterday but today it stabilized. (A good showing, all things being considered–but in no way decisive going forward).
    * Gold +$5/oz.
    * Crude oil +$0.50 and the rise is taking up some energy stocks.
    * The Russell returned to the spotlight.
    * Life insurance–particularly Lincoln National (LNC) (on an upgrade). Hartford Financial Services (HIG) gets a small lift.
    * Retail returned from the depths. The standouts–L Brands (LB) , Kohl’s (KSS) , Bed Bath (BBBY) , Nordstrom (JWN) and Gap (GPS) .
    * Ag equipment–after an analyst upgrade yesterday.
    * Brokerages.
    * Homebuilders catch a bid.
    * Day one of the Masters Golf Tournament.

Top 10 Undervalued Stocks For 2018: EPAM Systems, Inc.(EPAM)

Advisors’ Opinion:

  • [By Anders Bylund, Chuck Saletta, and Brian Feroldi]

    Read on to see why they pickedAllstate(NYSE:ALL),EPAM Systems(NYSE:EPAM), andUniversal Display(NASDAQ:OLED).

    Image source: Getty Images.

Top 10 Undervalued Stocks For 2018: Navidea Biopharmaceuticals, Inc.(NAVB)

Advisors’ Opinion:

  • [By Monica Gerson]

    Navidea Biopharmaceuticals Inc (NYSE: NAVB) shares rose 8.80 percent to $0.950 in pre-market trading as the company reported an unsolicited offer to refinance CRG loan.

Top 10 Undervalued Stocks For 2018: Meredith Corporation(MDP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Meredith Corporation (NYSE: MDP), a company that owns multiple TV stations, digital and mobile operations and other media platforms, agreed to acquire Time Inc (NYSE: TIME), the content company best known for operating People, Time, Fortune, and Sports Illustrated magazines.

  • [By Nelson Hem]

    See what Barron's feels the prospects are for Energy Transfer Partners LP (NYSE: ETP) if it cuts its distribution and dumps its general partner, and salesforce.com, inc. (NYSE: CRM) with its generous potential upside. Also whether regional banks like Zions Bancorp (NASDAQ: ZION) could see a boost from a proposed regulatory change, and the sweetheart deal the Koch brothers got with Meredith Corporation (NYSE: MDP).

  • [By Lisa Levin]

    Meredith Corporation (NYSE: MDP), a company that owns multiple TV stations, digital and mobile operations and other media platforms, agreed to acquire Time Inc (NYSE: TIME), the content company best known for operating People, Time, Fortune, and Sports Illustrated magazines.

  • [By Douglas A. McIntyre]

    Meredith Corp. (NYSE: MDP), the publishing, database and television station owner, has been described in several media reports as the most likely buyer of Time Inc. (NYSE: TIME). However, there are reports that the talks have stalled over valuation, which many experts believe will need to be above $20 a share to get the approval of Time’s board.

Top 10 Undervalued Stocks For 2018: Gap, Inc. (The)(GPS)

Advisors’ Opinion:

  • [By Peter Graham]

    Mid cap clothing retailer stockThe Gap Incs (NYSE: GPS)reported Q1 earnings after the market closed Thursday with shares up in premarket trading Old Navy, the company’s biggest brand by revenue,posted its fifth consecutive year of sales growth in 2016. Net sales were flat year over year at$3.4 billion (the translation of foreign currencies into U.S. dollars negatively impacted net sales by about $11 million). Gap Incs comparable sales were up 2% versus a 5% decrease last year with Old Navy Globals comparable salesup 8% versus negative 6% last year; Gap Globals comparable saleswere down4% versus negative 3%last year; and Banana Republic Globals comparable saleswere down4% versus negative 11% last year. Net income was $143 million versus net income of$127 million.

  • [By WWW.THESTREET.COM]

    * The market bent yesterday but today it stabilized. (A good showing, all things being considered–but in no way decisive going forward).
    * Gold +$5/oz.
    * Crude oil +$0.50 and the rise is taking up some energy stocks.
    * The Russell returned to the spotlight.
    * Life insurance–particularly Lincoln National (LNC) (on an upgrade). Hartford Financial Services (HIG) gets a small lift.
    * Retail returned from the depths. The standouts–L Brands (LB) , Kohl’s (KSS) , Bed Bath (BBBY) , Nordstrom (JWN) and Gap (GPS) .
    * Ag equipment–after an analyst upgrade yesterday.
    * Brokerages.
    * Homebuilders catch a bid.
    * Day one of the Masters Golf Tournament.

  • [By Peter Graham]

    A long term performance chart shows shares of athletic apparel or yoga space playersLululemon Athletica, Under Armour Inc (NYSE: UA) and The Gap Inc (NYSE: GPS) now underperforming while Nike Inc (NYSE: NKE) peaked in late 2015 with a slight downtrend since then:

Top 10 Undervalued Stocks For 2018: Sally Beauty Holdings, Inc.(SBH)

Advisors’ Opinion:

  • [By Paul Ausick]

    Sally Beauty Holdings Inc. (NYSE: SBH) posted a new 52-week low of $20.22 on Friday, down 0.3% compared with Thursday’s closing price of $20.28. The stock’s 52-week high is $32.93. Volume was more than triple the daily average of around 2 million shares. The company had no specific news Friday.

Top 10 Undervalued Stocks For 2018: The NeutriSci International (NU)

Advisors’ Opinion:

  • [By Bryan Murphy]

    In the grand scheme of things it shouldn’t be surprising, though odds are good at least a few people are surprised at how quickly it happened. That is, health supplement and healthy-foods brand name NeutriSci International Inc (CVE:NU) and the developer of a cannabis-infusion technology — a means of packing more CBD into hemp oil — called Lexaria Bioscience Corp (OTCMKTS:LXRP) have finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

    The benefits of cannabidiol, found in hemp and marijuana, are relatively well understood by the market at this point. Cannabidiol can do a human body a lot of good, like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more. Pterostilbene is the lesser-known of the two components of the new tablet, but no less impressive and no less beneficial. Pterostilbene is known to combat high cholesterol, high blood pressure, and oxidative stress. Combining the two is a real one-two punch for the health-conscious.

    That’s what made November’s news so exciting… NeutriSci International has an established name and marketing channel, while Lexaria Bioscience has the science that makes hemp oil far more functional. Indeed, to fully appreciate the upside for LXRP, one has to embrace Lexaria’s science and why it matters.

    The bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short,

  • [By Matthew Briar]

    Last week — to the day, in fact — Lexaria Bioscience Corp (OTCMKTS:LXRP) announced it was teaming up with neutraceutical company NeutriSci International Inc (CVE:NU) to create a new kind of health supplement that gave consumers the ability to tap into the benefits of hemp. We hailed it as the shape of things to come. What we didn’t know, however, was how quickly those things would take shape. Just this morning the company told LXRP shareholders it was already forging another such symbiotic relationship…. this one with Hempco Food and Fiber Inc (CVE:HEMP).

    Simply put, Lexaria Bioscience is focused on improving the bioavailability of the healthy stuff found in food, supplements, vitamins, and yes, even in cannabis and hemp.

    It’s not widely recognized, but the bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity. Hemp, and hemp oil to be exact, can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    The future for Lexaria Bioscience is partnerships… licensing its science and know-how to companies with existing product lines and distribution networks that can easily inject hemp

  • [By Matthew Briar]

    Indeed, it’s also garnered interest from business partners. In November, Lexaria Bioscience and NeutriSci International Inc (CVE:NU) jointly announced they were entering a joint venture that would utilize Lexaria Bioscience’s proprietary infusion platform and tap into NeutriSci International’s existing distribution network to create and market a whole new supplement product line. In January, the duo announced it had finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

  • [By Matthew Briar]

    What do you get when you cross a science that drastically improves the absorption of cannabidiol (the healthy component of cannabis) with pterostilbene (an antioxidant) tablet? It’s not a joke in search of a punch line. It’s going to be the health supplement millions of consumers have been waiting for, brought to them by a joint venture between NeutriSci International Inc (CVE:NU) and Lexaria Bioscience Corp (OTCMKTS:LXRP). The two companies announced this morning they were entering a joint venture that would utilize Lexaria Bioscience’s proprietary infusion platform and tap into NeutriSci International’s existing distribution network to create and market a whole new supplement product line.

    Lexaria has developed and patented a technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity.

    Just to be clear, hemp and marijuana are not the same thing. Hemp doesn’t have any tetrahydrocannabinol (or THC) in it, which is the key driver of its psychoactive — the ‘high’ — response. Hemp, and hemp oil to be exact, does have cannabidiol in it though, and for those who’ve been following the saga of medical marijuana and cannabis, they’ll know cannabidiol can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    NeutriSci International is Canadian corporation that specializes in the marketing, development and distribution of proprietary nutraceuticals. It’s got a rather wide array of products in its portfolio, but the one of immediate interest is its pterostilbene, as it fits best with the hemp-absorption technology Lexaria Bioscience brings to the table.

    Pterostilbene (found in blueberries, by the way) is o

Top 10 Undervalued Stocks For 2018: Triple-S Management Corporation(GTS)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap Triple-S Management Corp (NYSE: GTS) is an independent licensee of the Blue Cross Blue Shield Association. It is one of the leading players in the managed care industry in Puerto Rico. Triple-S Management has the exclusive right to use the Blue Cross Blue Shield name and mark throughout Puerto Rico, the U.S. Virgin Islands, and Costa Rica. With more than 50 years of experience in the industry, Triple-S Management offers a broad portfolio of managed care and related products in the Commercial, Medicare Advantage, and Medicaid markets under the Blue Cross Blue Shield marks. It also provides non-Blue Cross Blue Shield branded life and property and casualty insurance in Puerto Rico.

best stock trading

Norwegian Cruise Lines (NCLH) was up nearly 7% on Wednesday afternoon, following its fourth-quarter earnings report.

Norwegian said that it earned 56 cents a share, a penny ahead of analysts’ expectations. Revenue rose 8.5% to $1.13 billion, also squeaking past the $1.11 billion consensus estimate.

For the full year, Norwegian said it expects to earn between $3.75 and $3.85 a share, with a midpoint a penny above the $3.79 average analyst estimate. It’s first-quarter EPS guidance of 36 cents also came in ahead of the 34-cent consensus.

Instinet analyst Harry Curtiswrites that after recent missteps, it was “vital” for Norwegian’s forecast to meet expectations but not seem too optimistic, a balancing act he believes the company achieved.

He reiterated a Buy rating and $52 price target on the stock:

best stock trading: Straight Path Communications Inc.(STRP)

Advisors’ Opinion:

  • [By Ashley Moore]

    We’ve compiled a list of the most heavily shorted stocks to show you which stocks have the most negative sentiment on the market…

    Company Name (Ticker)Short FloatShare PriceHanwha Q Cells Co. Ltd. (Nasdaq ADR: HQCL)98.52%$ 8.88Renren Inc. (NYSE: RENN)91.59%$ 8.53Weight Watchers International Inc. (NYSE: WTW)67.92%$12.57INSYS Therapeutics Inc. (Nasdaq: INSY)66.71%$10.74Twilio Inc. (NYSE: TWLO)66.34%$33.17Nutanix Inc. (Nasdaq: NTNX)65.65%$31.96Fitbit Inc. (NYSE: FIT)55.15%$ 6.06Weibo Corp. (Nasdaq ADR: WB)53.83%$55.26RPC Inc. (NYSE: RES)53.62%$21.19Straight Path Communications Inc. (NYSEMKT: STRP)49.27%$34.79Momo Inc. (Nasdaq ADR: MOMO)48.63%$26.80Seritage Growth Properties (NYSE: SRG)46.91%$44.87Lannett Company Inc. (NYSE: LCI)45.46%$23.00Gogo Inc. (Nasdaq: GOGO)43.98%$ 9.10Altisource Portfolio Solutions SA (Nasdaq: ASPS)42.78%$22.73Cheetah Mobile Inc. (NYSE ADR: CMCM)40.86%$10.00

    Some investors think the only way to profit from the stock market is to buy stocks and wait for the price to rise. However, these investors are missing out on the massive profit opportunity that comes from shorting stocks.

best stock trading: Vanguard Natural Resources LLC(VNR)

Advisors’ Opinion:

  • [By Cameron Swinehart]

    Going forward I will be looking to add investments on my watchlist and trim other positions. It will be interesting to see how an overweight commodity portfolio will perform relative to the rest of the market.

     Cost Basis# SharesCurrent Price% of PortfolioCurrent ValueReturnMetal/Miners      Sprott Physical Gold Trust (PHYS)$12.4985$11.043.75%$938.40-13.13%Sprott Physical Silver Trust (PSLV)$7.95125$8.744.37%$1,092.509.04%FreePort-McMoran (FCX)$31.6731$33.874.20%$1,049.976.50%Ishares MSCI Global Gold Miners ETF (RING)$13.0695$10.644.04%$1,010.80-22.74%Energy      Statoil ASA(STO)$21.7940$22.683.63%$907.203.92%Vanguard Natural Resources LLC (VNR)$27.5636$27.874.01%$1,003.321.11%ConocoPhillips (COP)$63.6822.43$71.006.37%$1,592.5310.31%Agriculture      CVR Partner LP (UAN)$26.3630.9$18.932.34%$584.94-39.25%Adecoagro$6.78125$7.443.72%$930.008.87%Archer-Daniels Midland (ADM)$34.8030$37.244.47%$1,117.206.55%Mixed Commodity      Powershares DB Commodity Index (DBC)$26.3540$25.954.15%$1,038.00-1.54%Sprott Resource Corp$3.34400$2.714.34%$1,084.00-23.25%    Total % of portfolio49.40%               Cost Basis12,666.00      Current Value12,348.86      Return-2.50%  Source: Investing For The Future Surge In Commodity Prices

    Disclosure: I am long ADM, FCX, UAN, AGRO, RING, VNR, SCPZF.PK, COP, DBC, PHYS, PSLV. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. (More…)

best stock trading: Navidea Biopharmaceuticals, Inc.(NAVB)

Advisors’ Opinion:

  • [By Monica Gerson]

    Navidea Biopharmaceuticals Inc (NYSE: NAVB) shares rose 8.80 percent to $0.950 in pre-market trading as the company reported an unsolicited offer to refinance CRG loan.

best stock trading: Alexco Resource Corp(AXU)

Advisors’ Opinion:

  • [By Cameron Saucier]

    Alexco Resource (NYSEMKT: AXU) operates in two segments: an environmental services business and a mining company. Its mining segment explores developments in Canada, while its environmental segment provides consulting and project management services in the United States and Canada. AXU is up over 400% YTD. The stock has been steadily rising since January. It isn’t clear what’s driving AXU upwards, other than general investor speculation. The stock is trading at $1.72 per share as of Monday intraday.

best stock trading: Callon Petroleum Company(CPE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

jim cramer stock picks

The financials have been playing the part of the potential silent killer to the monster rally that started almost a year ago to the week. Over the last two weeks, the large cap financials have tumbled, which is starting to cause weakness for the market. The reason behind the draw lower is another migration to technology stocks, but there’s more.

The continued uncertainty around the players at the Federal Open Market Committee (FOMC) as well as what action will be taken on interest rates in 2018 is playing a heavy hand in keeping interest rates in-check. This, along with the tug-of-war around any potential tax overhaul has investors looking at the financials with a higher risk assumption.

Today’s three big stock charts looks at Bank of America Corp (NYSE:BAC), Citigroup Inc (NYSE:C) and JPMorgan Chase & Co. (NYSE:JPM) as three of the stock charts that are currently pulling the financials into a potential short-term bearish outlook.

Bank of America Corp (BAC)

jim cramer stock picks: Multi Packaging Solutions International Limited(MPSX)

Advisors’ Opinion:

  • [By Bradley Seth McNew]

    Multi Packaging Solutions International Ltd. (NYSE:MPSX) shares jumped 23% as of noon EST today, on the news that the packaging company would be acquired by WestRock Company (NYSE:WRK) in a deal worth $2.3 billion, including nearly $900 million of debt.

jim cramer stock picks: Cardtronics, Inc.(CATM)

Advisors’ Opinion:

  • [By Timothy Green]

    Non-bank ATM operator Cardtronics (NASDAQ:CATM) slumped on Friday despite reporting fourth-quarter results that beat analyst estimates on all fronts. The culprit driving the decline may be the company’s 2017 guidance, which calls for a decline in adjusted EPS. At 2:30 p.m. EST, the stock was down about 10%.

jim cramer stock picks: BiondVax Pharmaceuticals Ltd.(BVXV)

Advisors’ Opinion:

  • [By Chris Lange]

    BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) reported that the scientific journal “Vaccine” published an article citing results from its flu vaccine. The “Vaccine” article, Back to the future: Immunization with M-001, reports that blood plasma samples from people who received M-001 in 2011 (as part of BiondVax’s BVX-005 clinical trial in the elderly) showed significantly increased protective antibodies against the new epidemic 2014/15 flu strain (A/Swiss) – a strain which did not exist when M-001 was administered to the BVX-005 participants.

jim cramer stock picks: Navidea Biopharmaceuticals, Inc.(NAVB)

Advisors’ Opinion:

  • [By Monica Gerson]

    Navidea Biopharmaceuticals Inc (NYSE: NAVB) shares rose 8.80 percent to $0.950 in pre-market trading as the company reported an unsolicited offer to refinance CRG loan.

jim cramer stock picks: Moneygram International, Inc.(MGI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Moneygram International Inc (NASDAQ: MGI) shares were also up, gaining 21 percent to $5.74 after the company reported upbeat Q4 earnings.

    Equities Trading DOWN

  • [By Ben Levisohn]

    Western Union (WU) soared to the top of the S&P 500 today after MoneyGram International (MGI) received a bid from Euronet Worldwide (EEFT).

    Agence France-Presse/Getty Images

    Shares of Western Union gained 3.5% to $20.27 today, while the S&P 500 fell 0.3% to 2,365.45.MoneyGram International surged 25% to $15.77, while Euronet Worldwide advanced 0.3% to $83.22.

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested shorting small capmoney transfer services stock Moneygram International (NASDAQ: MGI):

jim cramer stock picks: Kelly Services Inc.(KELYA)

Advisors’ Opinion:

  • [By David Milstead]

    One such outfit is Kelly Services (KELYA). The Troy, Mich., company places temporary employees in a variety of fields, such as law, health care, computing and finance. Although recent job reports have been strong, S&P Capital IQ analyst Michael Jaffe sees employers remaining cautious in their hiring practices and using the kind of temporary workers Kelly specializes in. Jaffe says Kelly is his top pick in the staffing sector, and he rates the stock a strong buy.

  • [By Monica Gerson]

    Kelly Services, Inc. (NASDAQ: KELYA) is projected to report its quarterly earnings at $0.28 per share on revenue of $1.35 billion.

    Silver Standard Resources Inc. (USA) (NASDAQ: SSRI) is expected to post a quarterly loss at $0.02 per share on revenue of $96.25 million.